Table 2.
KM,Pn (µM) | KM,NAD+ (µM) | kcat (s−1) | |
---|---|---|---|
PhnY constructs with PnAA | |||
Wild type | 3.2 ± 0.7 | 58 ± 9 | 2.2 ± 0.1 |
Arg108Ala | 9.7 ± 0.8 | 18 ± 2 | 0.051 ± 0.001 |
Asn158Ala | 29 ± 9 | 40 ± 6 | 0.010 ± 0.001 |
Glu254Ala | n.d.1 | n.d. | n.d. |
Arg290Ala | 5.1 ± 0.6 | 75 ± 8 | 0.12 ± 0.003 |
Cys291Ala | n.d. | n.d. | n.d. |
Glu385Ala2 | 19 ± 3 | 370 ± 10 | 0.19 ± 0.03 |
Arg447Ala | 150 ± 20 | 54 ± 1 | 0.076 ± 0.003 |
PhnY constructs with G3P | |||
Wild type | 97 ± 7 | 530 ± 50 | 0.098 ± 0.003 |
Cys291Ala | n.d. | n.d. | n.d. |
PhnY constructs with 3-OPP | |||
Wild type | 3300 ± 100 | n.d. | 1.5 ± 0.1 |
Cys291Ala | n.d. | n.d. | n.d. |
GAPDH with various substrates | |||
PnAA | n.d. | n.d. | n.d. |
3-OPP | 1500 ± 300 | 330 ± 20 | 0.038 ± 0.022 |
G3P (racemic) | 25 ± 7 | 22 ± 1 | 22 ± 2 |
n.d.: Not determined. Low levels of detectable activity precluded kinetic parameter determination.
: This mutant displayed substrate inhibition (see Figure S6); the Ki,PnAA was 420 ± 70 µM.